BNP Paribas Financial Markets’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-679
| Closed | -$3.31K | – | 5462 |
|
|
2025
Q1 | $3.31K | Sell |
679
-3,866
| -85% | -$23.2K | ﹤0.01% | 4918 |
|
|
2024
Q4 | $37.9K | Sell |
4,545
-14,016
| -76% | -$122K | ﹤0.01% | 4537 |
|
|
2024
Q3 | $193K | Buy |
18,561
+17,778
| +2,270% | +$296K | ﹤0.01% | 3266 |
|
|
2024
Q2 | $15.4K | Sell |
783
-4,322
| -85% | -$86.6K | ﹤0.01% | 3673 |
|
|
2024
Q1 | $131K | Sell |
5,105
-21,143
| -81% | -$542K | ﹤0.01% | 3368 |
|
|
2023
Q4 | $724K | Buy |
26,248
+15,523
| +145% | +$946K | ﹤0.01% | 2589 |
|
|
2023
Q3 | $652K | Sell |
10,725
-5,790
| -35% | -$407K | ﹤0.01% | 2579 |
|
|
2023
Q2 | $1.09M | Sell |
16,515
-14,110
| -46% | -$1.03M | ﹤0.01% | 2149 |
|
|
2023
Q1 | $1.95M | Buy |
30,625
+20,132
| +192% | +$2.3M | ﹤0.01% | 1833 |
|
|
2022
Q4 | $1.45M | Sell |
10,493
-5,979
| -36% | -$842K | ﹤0.01% | 1947 |
|
|
2022
Q3 | $2.09M | Buy |
16,472
+7,177
| +77% | +$812K | ﹤0.01% | 1935 |
|
|
2022
Q2 | $770K | Sell |
9,295
-3,671
| -28% | -$285K | ﹤0.01% | 2382 |
|
|
2022
Q1 | $1.26M | Sell |
12,966
-1,884
| -13% | -$249K | ﹤0.01% | 2156 |
|
|
2021
Q4 | $2.97M | Buy |
14,850
+7,216
| +95% | +$1.7M | ﹤0.01% | 1723 |
|
|
2021
Q3 | $1.89M | Buy |
7,634
+1,735
| +29% | +$496K | ﹤0.01% | 1941 |
|
|
2021
Q2 | $2.44M | Buy |
5,899
+1,994
| +51% | +$790K | ﹤0.01% | 1656 |
|
|
2021
Q1 | $1.52M | Sell |
3,905
-488
| -11% | -$240K | ﹤0.01% | 1863 |
|
|
2020
Q4 | $2.46M | Buy |
4,393
+2,060
| +88% | +$1.31M | ﹤0.01% | 1518 |
|
|
2020
Q3 | $1.63M | Buy |
2,333
+932
| +67% | +$727K | ﹤0.01% | 1598 |
|
|
2020
Q2 | $1.11M | Sell |
1,401
-1,052
| -43% | -$793K | ﹤0.01% | 1761 |
|
|
2020
Q1 | $1.46M | Buy |
2,453
+1,366
| +126% | +$1.33M | ﹤0.01% | 1668 |
|
|
2019
Q4 | $1.24M | Sell |
1,087
-3,850
| -78% | -$4.19M | ﹤0.01% | 1918 |
|
|
2019
Q3 | $5.87M | Buy |
4,937
+3,407
| +223% | +$5.2M | 0.01% | 1007 |
|
|
2019
Q2 | $2.52M | Buy |
1,530
+545
| +55% | +$943K | 0.01% | 1354 |
|
|
2019
Q1 | $2.01M | Sell |
985
-442
| -31% | -$778K | ﹤0.01% | 1390 |
|
|
2018
Q4 | $1.83M | Buy |
1,427
+472
| +49% | +$724K | ﹤0.01% | 1350 |
|
|
2018
Q3 | $1.81M | Buy |
955
+119
| +14% | +$246K | ﹤0.01% | 1529 |
|
|
2018
Q2 | $1.7M | Sell |
836
-807
| -49% | -$1.84M | ﹤0.01% | 1546 |
|
|
2018
Q1 | $3.63M | Buy |
1,643
+867
| +112% | +$2.21M | 0.01% | 1138 |
|
|
2017
Q4 | $1.79M | Buy |
776
+356
| +85% | +$723K | ﹤0.01% | 1547 |
|
|
2017
Q3 | $748K | Buy |
420
+25
| +6% | +$34.9K | ﹤0.01% | 1754 |
|
|
2017
Q2 | $537K | Buy |
395
+331
| +517% | +$399K | ﹤0.01% | 1879 |
|
|
2017
Q1 | $75.6K | Sell |
64
-157
| -71% | -$160K | ﹤0.01% | 2594 |
|
|
2016
Q4 | $177K | Sell |
221
-17
| -7% | -$13.5K | ﹤0.01% | 2272 |
|
|
2016
Q3 | $209K | Buy |
238
+125
| +111% | +$90.5K | ﹤0.01% | 1724 |
|
|
2016
Q2 | $63.4K | Buy |
113
+82
| +265% | +$46.4K | ﹤0.01% | 2247 |
|
|
2016
Q1 | $17.2K | Sell |
31
-30
| -49% | -$18.4K | ﹤0.01% | 2169 |
|
|
2015
Q4 | $51K | Sell |
61
-113
| -65% | -$113K | ﹤0.01% | 2800 |
|
|
2015
Q3 | $193K | Buy |
174
+120
| +222% | +$219K | ﹤0.01% | 1979 |
|
|
2015
Q2 | $118K | Buy |
54
+18
| +50% | +$36.7K | ﹤0.01% | 1995 |
|
|
2015
Q1 | $56.3K | Buy |
+36
| New | +$47.5K | ﹤0.01% | 1887 |
|
|
2014
Q4 | – | Sell |
-99
| Closed | -$45.9K | – | 2137 |
|
|
2014
Q3 | $45.9K | Buy |
99
+86
| +662% | +$39.7K | ﹤0.01% | 2650 |
|
|
2014
Q2 | $6.52K | Buy |
13
+10
| +333% | +$3.21K | ﹤0.01% | 2469 |
|
|
2014
Q1 | $733 | Buy |
3
+1
| +50% | +$303 | ﹤0.01% | 2956 |
|
|
2013
Q4 | $629 | Buy |
+2
| New | +$559 | ﹤0.01% | 3913 |
|
Other funds holding BLUE
BNP Paribas Financial Markets's BLUE Position: Q2 2025 in Review
BNP Paribas Financial Markets sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 679 shares — an estimated $3.31K sold.
BNP Paribas Financial Markets first reported a position in BLUE in Q4 2013 and held it in 45 quarters. The position peaked at $5.87M in Q3 2019. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.
- BNP Paribas Financial Markets reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
- BNP Paribas Financial Markets sold 679 bluebird bio shares in Q2 2025, an estimated $3.31K.
- BNP Paribas Financial Markets first reported a position in bluebird bio in Q4 2013 and held it in 45 quarters.
- BNP Paribas Financial Markets's bluebird bio position peaked at $5.87M in Q3 2019.
- 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2025, filed 14 Aug 2025.